Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
2011

Comparing Drug-Eluting Stents and Bare Metal Stents in Heart Procedures

Sample size: 35438 publication 10 minutes Evidence: moderate

Author Information

Author(s): Robert W. Yeh, Malini Chandra, Charles E. McCulloch, Alan S. Go

Primary Institution: Massachusetts General Hospital

Hypothesis

Is there a mortality benefit associated with drug-eluting stents compared to bare metal stents in patients undergoing percutaneous coronary intervention?

Conclusion

The study found that while drug-eluting stents suggested a mortality benefit in observational studies, a more rigorous analysis showed no significant differences in outcomes compared to bare metal stents.

Supporting Evidence

  • Drug-eluting stents were used in 53.9% of the procedures analyzed.
  • Patients receiving drug-eluting stents had lower rates of death and myocardial infarction in observational studies.
  • Propensity-score methods suggested a mortality benefit for drug-eluting stents.
  • A stent era comparison showed no significant differences in outcomes between stent types.
  • Patients receiving bare metal stents had higher comorbidities after the introduction of drug-eluting stents.

Takeaway

Doctors wanted to see if a special type of heart stent helps people live longer than a regular one. They found that while some studies said it did, a better way of checking showed it didn't really make a difference.

Methodology

The study used propensity-score adjustment, matching, and stent-era comparison to analyze outcomes after PCI with drug-eluting and bare metal stents.

Potential Biases

There is a risk of bias due to differences in patient characteristics between those receiving drug-eluting and bare metal stents.

Limitations

The study may be limited by unmeasured confounding factors influencing stent selection.

Participant Demographics

Participants were health plan members aged 30 years and older, with a mix of comorbidities including diabetes and hypertension.

Statistical Information

P-Value

<0.001

Confidence Interval

0.39 - 0.63

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1741-7015-9-78

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication